Progressive multiple sclerosis (PMS) remains a major clinical challenge due to its complex pathophysiology and limited therapeutic options. While disease-modifying therapies have significantly improved prognosis for relapsing forms of multiple sclerosis (RMS), effective treatments for the progres…